What is the maximum 24‑hour dose of Zofran (ondansetron) for an adult, both oral and intravenous?

Maximum 24-Hour Dose of Zofran (Ondansetron)

For adults, the maximum 24-hour dose of ondansetron is 16 mg for both oral and intravenous routes when used for breakthrough therapy in radiation-induced nausea/vomiting, though higher doses up to 48 mg IV (0.15 mg/kg × 3 doses, maximum 16 mg per dose) may be used specifically for highly emetogenic chemotherapy. 1, 2

Context-Specific Maximum Doses

For Chemotherapy-Induced Nausea/Vomiting (CINV)

• Standard regimen: 0.15 mg/kg IV per dose for 3 doses (maximum 16 mg per dose)

  • First dose: 30 minutes before chemotherapy
  • Second dose: 4 hours after first dose
  • Third dose: 8 hours after first dose
  • Total daily maximum: 48 mg IV (three 16 mg doses) 2

• Alternative single-dose regimen: 32 mg IV as a single dose before chemotherapy 2

  • Research supports this approach, though the three-dose regimen remains standard 3, 4

For Postoperative Nausea/Vomiting (PONV)

• Single dose: 4 mg IV (given over 2-5 minutes)
• No additional benefit from administering a second 4 mg dose postoperatively in patients who already received prophylactic dosing 2
• Effective maximum: 4 mg in 24 hours for this indication

For Radiation-Induced Nausea/Vomiting

• Prophylactic: 8 mg oral or IV once to twice daily
• Breakthrough therapy: Titrate up as needed to maximum of 16 mg oral or IV daily 1

Important Caveats

Severe Hepatic Impairment

• Maximum dose: 8 mg total in 24 hours (single dose infused over 15 minutes)
• This applies only to first-day chemotherapy administration
• No data exists beyond first-day use in this population 2

Route Considerations

The FDA label 2 specifies:

• IV formulation for CINV: Must be diluted before administration and infused over 15 minutes
• IV formulation for PONV: Does not require dilution, given over 2-5 minutes
• Oral and IV dosing are generally equivalent for most indications

Clinical Pitfalls

• Do not exceed 16 mg per single IV dose outside of chemotherapy protocols, as higher single doses have not shown additional benefit and may increase cardiac risks
• The 32 mg single-dose regimen is specifically for highly emetogenic chemotherapy and should not be extrapolated to other indications 2
• Research suggests that 24 mg oral once daily may be more effective than 8 mg twice daily for cisplatin-based chemotherapy 3, but the FDA-approved maximum remains 16 mg for breakthrough use in radiation therapy

In summary: The practical maximum is 16 mg/24 hours for most indications, with the exception of highly emetogenic chemotherapy where up to 48 mg IV (as three divided doses) is standard, or 32 mg IV as a single alternative dose.